Skip to main content
OpenTrials

Clinical trial condition

Metabolism, Inborn Errors

Explore clinical trials studying Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

2,499 public trials 456 recruiting studies
Refine in advanced search Browse all conditions

Metabolism, Inborn Errors trial results

Completed

β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)

NCT01470989

Conditions
Acute Gouty Arthritis Flares, Arthritis, Arthritis, Gouty, +11 more
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Norwalk, California, United States
  • Novartis Investigative Site Pasadena, California, United States
View all 56 locations
View Trial Details
Completed

Long Term Study of Canakinumab (ACZ885) in Patients With Gout

NCT00927810

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Novartis Investigative site Seattle, Washington, United States
  • Novartis Investigative site Capital Federal Buenos Aires, Argentina
  • Novartis Investigative site Jette, Belgium
  • Novartis Investigative site Barranquilla, Colombia
View all 45 locations
View Trial Details
Completed

A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease

NCT00430625

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Hipolito Yrigoyen Buenos Aires, Argentina
  • Shaare Zedek Medical Center Jerusalem, Israel
  • Sociedad Espanola de Socorros Mutuos Asunción, Paraguay
  • National Research Center for Haematology Moscow, Russia
View Trial Details
Completed

Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

NCT03156621

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Regeneron Research Site Boca Raton, Florida, United States
  • Regeneron Research Site New York, United States
  • Regeneron Research Site Cincinnati, Ohio, United States
  • Regeneron Study Site Dallas, Texas, United States
View all 28 locations
View Trial Details
Completed

A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®

NCT00920647

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
Locations
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Birmingham Children's Hospital NHS Foundation Trust Birmingham, United Kingdom
View Trial Details
Completed

Weight Loss for Obese Individuals With Gout

NCT03664167

Conditions
Arthritis, Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +17 more
Locations
  • Department of Rheumatology, the Parker Institute, Frederiksberg and Bispebjerg Hospital Frederiksberg, Copenhagen, Denmark
View Trial Details

Related conditions